Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2004

01-05-2004 | Case Report

EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation

Authors: Naohiro Sekiguchi, Junko Nishimoto, Ryuji Tanosaki, Nobuko Kubota, Yukiko Yokota, Yukio Kobayashi, Takashi Watanabe, Masahiro Kami, Yoichi Takaue, Yoshihiro Matsuno, Kensei Tobinaia

Published in: International Journal of Hematology | Issue 4/2004

Login to get access
Metadata
Title
EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
Authors
Naohiro Sekiguchi
Junko Nishimoto
Ryuji Tanosaki
Nobuko Kubota
Yukiko Yokota
Yukio Kobayashi
Takashi Watanabe
Masahiro Kami
Yoichi Takaue
Yoshihiro Matsuno
Kensei Tobinaia
Publication date
01-05-2004
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.03175

Other articles of this Issue 4/2004

International Journal of Hematology 4/2004 Go to the issue

Case Report

Successful Micafungin (FK463) Treatment of Invasive Pulmonary Aspergillosis in a Patient with Acute Lymphoblastic Leukemia in a Phase II Study

Case Report

Primary Renal Lymphoma Presenting with Chronic Low-Grade Fever

OriginalPaper

Expression of Human Tumor-Associated Antigen RCAS1 in Adult T-Cell Leukemia/Lymphoma

OriginalPaper

Familial B-cell Chronic Lymphocytic Leukemia in a Population of Patients from Southern Italy

OriginalPaper

Lentiviral gp34/OX40L Gene Transfer into Dendritic Cells Facilitates Alloreactive CD4+ T-Cell Response In Vitro

Review Article

Bone Marrow Cells and Myocardial Regeneration
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits